Primary Ciliary Dyskinesia for Bronchiectasis
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to help determine how often primary ciliary dyskinesia (PCD) is present but undiagnosed in adults with bronchiectasis.
Are You a Good Fit for This Trial?
This study is for adults aged 18 or older who have been diagnosed with bronchiectasis confirmed by a CT scan.Inclusion Criteria
What Are the Treatments Tested in This Trial?
Trial Overview
Researchers are collecting nasal samples and measuring nitric oxide levels in the nose to find out how common undiagnosed primary ciliary dyskinesia (PCD) is among adults with bronchiectasis. No medications are given.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
patients with a known or new diagnosis of bronchiectasis
Find a Clinic Near You
Who Is Running the Clinical Trial?
Indiana University
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.